Storia in 1 fonti

News on AstraZeneca, Cytokinetics, Novartis and more — what to look out for at ESC 2026

ESC 2026 preview: AstraZeneca/Ionis' Wainua trial miss, Cytokinetics' aficamten push into nHCM, and Novartis' pacibekitug in focus after Novo's IL-6 flop.

Raccontata da

endpoints.news

Timeline cronologica

lunedì 24 agosto 2026·endpoints.news
News on AstraZeneca, Cytokinetics, Novartis and more — what to look out for at ESC 2026
ESC 2026 preview: AstraZeneca/Ionis' Wainua trial miss, Cytokinetics' aficamten push into nHCM, and Novartis' pacibekitug in focus after Novo's IL-6 flop.